← All indications
Cough
A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
Subtype terms (1)
More specific conditions that are subtypes of Cough in the MeSH hierarchy.
Drugs by status
Approved for this indication (26)
- phenylephrine
- benzonatate
- carrageenan
- diphenhydramine
- dexchlorpheniramine maleate
- echinacea
- guaifenesin
- homatropine
- Eucalyptol
- noscapine
- menthol
- curcuma longa
- bromeliace
- camphor
- caramiphen hydrochloride
- novedrine
- ortoxine
- dextromethorphan
- pseudoephedrine
- chlophedianol
- eucalyptus oil
- methylcatechol
- tussidin
- pipazethate
- ethylmorphine
- lianhua qingke
Phase 4 trials (25)
- montelukast
- black cohosh
- cocoa bean
- prednisone
- carbocisteine lysine
- sevoflurane
- ivy leaves
- mepolizumab
- pneumococcal 13-valent conjugate vaccine
- magnesium sulfate
- lidocaine
- bepotastine
- cyclodextrin
- dexmedetomidine
- methacholine
- 10-valent Pneumococcal Conjugate Vaccine
- fentanyl
- thyme
- anacaulase
- carbinoxamine maleate
- sodium chloride
- omeprazole
- esomeprazole
- remifentanil
- lianhuaqingwen
Phase 3 trials (24)
Phase 2 trials (37)
- ambroxol
- amitriptyline
- Eliapixant
- capsaicin
- cromoglicic acid
- duloxetine
- fp01
- gsk2339345
- gsk2798745
- indantadol
- nalbuphine
- orvepitant
- pdc-748
- sch-486757
- serlopitant
- bradanicline
- levocetirizine
- xen-d0501
- zinc dichloride
- albuterol
- midazolam
- capsicum
- pregabalin
- rolapitant
- suplatast tosylate
- interferon alpha-2b
- hesperidin
- P2X3
- ax-8
- xiao'er zhike
- +7 more
Phase 1 trials (14)
Other trials (32)
- mannitol
- propofol
- spirulina
- agave
- ketamine
- oxycodone
- Ebastine
- ferric sulfate
- beclomethasone
- nitazoxanide
- formoterol
- remimazolam
- rocuronium
- su-huang
- citrus honey
- eucalyptus honey
- labiatae honey
- magnesium alginate
- maple syrup
- perilla extract
- silan date extract
- budesonide
- pinellia
- viusid
- procaterol
- terpin monohydrate
- citric acid
- salmon
- mustard
- radish seed
- +2 more
Organizations
Organization Involved with Phase 4 Indications (25)
- AstraZeneca
- Pfizer
- PharmEvo Pvt Ltd
- Fundacion Clinica Valle del Lili
- Cedars-Sinai Medical Center
- University of London
- Guangzhou Medical University
- Queen's University, Belfast
- University of Hull
- University of Manchester
- University of Vermont
- Yonsei University
- Association Asthma, Bulgaria
- B.P. Koirala Institute of Health Sciences
- Capital Medical University
- Chongqing Medical University
- Zhejiang University
- Jiao Tong University
- University of Oxford
- Federal University of Pernambuco
- Technion University
- University of North Carolina at Chapel Hill
- Isala Clinics, Zwolle, The Netherlands
- Aerocrine AB
- Yeshiva University
Organization Involved with Phase 3 Indications (29)
- Ache Laboratorios Farmaceuticos S.A.
- Merck
- Engelhard Arzneimittel GmbH & Co.KG
- Respicopea Limited
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Swiss National Science Foundation
- Azad University
- Johns Hopkins University
- Kyung Hee University
- Seoul National University
- University of Leicester
- University of Nottingham
- University of South Florida
- University of Brasilia
- Peking University
- University of Basel
- Azidus
- Isfahan University
- Freeman Health System
- Albany House Medical Centre
- Staploe Medical Centre
- Sheepcot Medical Centre
- Mortimer Surgery
- Ormeau Road Health Centre
- EMS S/A
- Hallym University
- Hyundai
- Dompe Pharmaceuticals
- Shijiazhuang Pharma Group (CSPC)
Organization Involved with Phase 2 Indications (35)
- Vernalis
- Sanofi
- Shionogi
- Novartis
- Bayer
- Bellus Health Inc
- Cerecor Inc
- GlaxoSmithKline
- Vyne Therapeutics Inc.
- Parexel
- Patara Pharma
- PhytoHealth Corporation
- Tasly Pharmaceuticals, Inc.
- Trevi Therapeutics
- Xention Ltd
- Amarillo Biosciences, Inc.
- NeRRe Therapeutics Ltd.
- National Heart, Lung, and Blood Institute (NHLBI)
- Vastra Gotaland Region
- Chang Gung University
- Hoosier Cancer Research Network
- McMaster University
- Shanghai University of Traditional Chinese Medicine
- Texas Tech University
- University of Florida
- University of Ottawa
- Afferent Pharmaceuticals
- University of Duisburg-Essen
- University of Gothenburg
- Department of Health and Human Services
- +5 more
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (25)
- Zarbee's Inc.
- BioGaia AB
- Otsuka
- Syntara
- National Health Service, United Kingdom
- Ajou University
- Cathay General Hospital
- Mahidol University
- Monash University
- Mongi Slim Hospital
- Saint-Joseph University
- University of Melbourne
- University of Bern
- Yuzuncu Yıl University
- Taichung Veterans General Hospital
- Tel Aviv University
- University of Turin
- Advanced Clinical Research Inc.
- University of Montreal
- KhonKaen University
- Ambulatory Pediatric Association
- The Ontario Thoracic Society of the Ontario Lung Association
- AllerGen NCE Inc.
- University of Lorraine
- Imperial College London